Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro

Treatment of hepatitis C virus (HCV) infection has been met with less than satisfactory results due primarily to its resistance to and significant side effects from alpha interferon (IFN-α). New classes of safe and broadly acting treatments are urgently needed. Cyclosporine (CsA), an immunosuppressi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Robida, John M., Nelson, Heather B., Liu, Zhe, Tang, Hengli
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2007
Sujets:
Vaccines and Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1900250/
https://ncbi.nlm.nih.gov/pubmed/17376913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02524-06
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires